BOTULINUM TOXIN IN OPHTHALMOLOGY
- 1 February 1988
- journal article
- Published by Wiley in Australian and New Zealand Journal of Ophthalmology
- Vol. 16 (1) , 15-20
- https://doi.org/10.1111/j.1442-9071.1988.tb01194.x
Abstract
Alan B. Scott selected, researched and developed Type A Botulinum toxin for clinical use in ophthalmology. This unique drug has proved invaluable for treatment of a number of conditions which are difficult to treat in ophthalmology and in a variety of other disciplines. The indications, methods and problems of its use are described and the results of treatment of 133 patients are discussed. Up to December 1986 over 13 000 patients have been treated in a multicentre international trial without significant complications.Keywords
This publication has 5 references indexed in Scilit:
- Botulinum Injections for StrabismusJournal of Pediatric Ophthalmology & Strabismus, 1984
- Botulinum Toxin Chemo-Denervation for Strabismus in Infants and ChildrenJournal of Pediatric Ophthalmology & Strabismus, 1984
- Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus SurgeryOphthalmology, 1980